• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Phenylpyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Phenylpyrimidines

Chemical Profile of 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine (CAS No. 1027064-22-7)

4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine, identified by the CAS number 1027064-22-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrimidine class, a heterocyclic aromatic ring structure that is widely recognized for its biological activity and pharmacological potential. The presence of both a bromine substituent at the 4-position of the phenyl ring and a methylsulfonyl group at the 2-position of the pyrimidine ring imparts unique chemical and biological properties, making it a valuable scaffold for drug discovery and development.

The structural features of 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine make it a versatile intermediate in synthetic chemistry. The bromine atom at the 4-position of the phenyl ring provides a reactive site for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings. These reactions are instrumental in constructing more complex molecular architectures, enabling the design of novel therapeutic agents. Additionally, the methylsulfonyl group at the 2-position of the pyrimidine ring contributes to the compound's lipophilicity and metabolic stability, which are critical factors in drug design.

In recent years, there has been growing interest in exploring the pharmacological properties of pyrimidine derivatives. Studies have demonstrated that modifications at specific positions within the pyrimidine core can significantly alter biological activity. For instance, compounds with substituents at the 2- and 4-positions have shown promise in inhibiting various enzymatic targets relevant to cancer, inflammation, and infectious diseases. The bromine substituent in 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine further enhances its utility as a building block for generating libraries of diverse compounds for high-throughput screening.

One of the most compelling applications of 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine is in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is implicated in numerous diseases, particularly cancer. By leveraging the reactivity of the bromine atom for fragment-based drug design or as a precursor for generating biaryl structures, researchers have been able to develop potent inhibitors targeting specific kinases. For example, derivatives of this compound have been investigated for their ability to inhibit tyrosine kinases, which are overexpressed in many cancers.

The methylsulfonyl group in 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine also contributes to its potential as an anti-inflammatory agent. Sulfonyl groups are known to modulate inflammatory pathways by inhibiting key enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX). Preclinical studies have suggested that pyrimidine-based sulfonamides may exhibit anti-inflammatory effects by interfering with pro-inflammatory mediator synthesis. This makes 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine a promising candidate for further investigation in therapeutic contexts where inflammation plays a significant role.

Advances in computational chemistry and molecular modeling have further enhanced the utility of 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine as a drug discovery tool. These techniques allow researchers to predict binding affinities and optimize molecular structures before conducting expensive wet-lab experiments. By integrating experimental data with computational predictions, scientists can accelerate the process of identifying lead compounds with high potential for further development into clinical candidates.

The synthesis of 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine typically involves multi-step organic transformations starting from readily available precursors. Key steps often include bromination of a phenyl derivative followed by sulfonylation at the pyrimidine ring. The precise control over reaction conditions is essential to achieve high yields and purity, which are critical for pharmaceutical applications. Recent methodologies have focused on greener synthetic routes, such as catalytic processes that minimize waste and energy consumption.

In conclusion, 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine (CAS No. 1027064-22-7) represents a significant advancement in medicinal chemistry due to its unique structural features and broad applicability in drug discovery. Its role as an intermediate for constructing complex molecular architectures, coupled with its potential biological activities, positions it as a valuable asset in ongoing research efforts aimed at developing novel therapeutic agents. As our understanding of disease mechanisms continues to evolve, compounds like 4-(4-Bromophenyl)-2-(methylsulfonyl)pyrimidine will undoubtedly play an increasingly important role in addressing unmet medical needs.

• 75175-89-2(Pyrimidine, 2-(methylsulfonyl)-4-[3-(trifluoromethyl)phenyl]-)
• 145276-34-2(Benzonitrile, 3-[2-(methylsulfonyl)-4-pyrimidinyl]-)
• 637352-78-4(PYRIMIDINE, 2-(METHYLSULFONYL)-4-[4-(TRIFLUOROMETHYL)PHENYL]-)
• 56734-11-3(2-Methanesulfonyl-4-phenyl-pyrimidine)
• 865425-40-7(4-(4-bromophenyl)-6-(difluoromethyl)-2-(ethanesulfonyl)pyrimidine)
• 31408-33-0(Pyrimidine, 5-(4-bromophenyl)-2-(methylsulfonyl)-)
• 778646-96-1(4-(4-Bromophenyl)-2-(methylthio)pyrimidine)
• 434941-56-7(4-(4-Chlorophenyl)-2-(methylsulfonyl)pyrimidine)
• 637354-25-7(Pyrimidine, 2-(methylsulfonyl)-4-(3-pyridinyl)-)
• 958727-25-8(2-(Methylsulfonyl)-4,6-diphenylpyrimidine)